Clinical Trial Update: Pilot Study to Assess the Pharmacokinetics of Intravenous Nabi 5% Hepatitis B Immune Globulin (Boca HBVIg) Used in Combination With Lamivudine for Patients With Hepatitis B Virus (HBV) Associated Liver Disease Undergoing Liver Transplantation [Phase 1, Phase 2]

View source ↗

Summary

This update notes the completion of a Phase 1/2 pilot pharmacokinetic study evaluating intravenous Nabi 5% Hepatitis B immune globulin (HBIG) in combination wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis Virus Associated Liver Disease

Drugs mentioned

• Boca HBVIg (Hepatitis B immune globulin)
• Lamivudine (lamivudine)

Snippet

Sponsor: Biotest Pharmaceuticals Corporation | Conditions: Hepatitis B Virus Associated Liver Disease | Phase 1, Phase 2 | Status: COMPLETED